February 2017

///February 2017

Stop tilting at windmills, Mr Trump & Co.

2018-09-04T13:00:36+00:00February 10th, 2017|2017/2018, February 2017, Putting it in context, Year|

Donald Trump and his fellow travellers in Europe are doing their countries a disservice by recklessly pulling up the drawbridge on immigration, writes India Inc. CEO Manoj Ladwa. Everyone knows that whenever their fortresses and castles came under siege, kings of old would pass the order to pull up the drawbridges and every able man would take up position to repel the invaders. And most of you will be familiar with the story of Don Quixote, the fictional medieval Spanish [...]

New globalisation paradigm in the offing

2018-08-06T13:40:35+00:00February 10th, 2017|2017/2018, February 2017, Last Word, Year|

Outbound FDI from India will increasingly be driven by a need to fill knowledge and product gaps aimed at the domestic market. Finance Minister Arun Jaitley has greased the wheels of the investment cycle with allocations of almost $90 billion for building roads, railway infrastructure, inland waterways, ports, airports and rural infrastructure for 2017-18. This massive public spending spree, marking a humungous increase over the figures for the current year, is expected to translate into large contracts for Indian and [...]

India and Vietnam: Pushing back the dragon

2018-05-18T13:04:09+00:00February 9th, 2017|2017/2018, Emerging Markets, February 2017, Year|

The comprehensive strategic partnership between New Delhi and Hanoi is playing an important role in ensuring balance of power in Asia

Rarely, if ever, does India weigh heavily on the minds of foreign leaders when they meet their counterparts from third countries. But when Chinese President Xi Jinping recently met Communist Party of Vietnam’s General Secretary Nguyen Phu Trong in Beijing, seasoned observers could sense that New Delhi was the invisible elephant in the room.

India and China: It’s complicated

2018-09-19T07:49:07+00:00February 9th, 2017|2017/2018, February 2017, India & China, Year|

An assertive China presents Prime Minister Modi with his most intractable foreign policy challenge, but there are indications that Beijing may be getting a little edgy. Mahatma Gandhi had said of his adversaries: “First they ignore you, then they laugh at you, then they fight you, then you win.” Much to the chagrin of many in New Delhi’s policy circles who saw India as a counterweight to China, Beijing has, at least publicly, refused to treat India as an equal. [...]

Thinking out of the box: Reconfiguring the India-Pakistan-China Triangle

2018-06-12T12:57:35+00:00February 9th, 2017|2017/2018, February 2017, India & China, Year|

A foreign policy observer believes it is time for India to move towards a more flexible approach towards China. It has been suggested that New Delhi’s bid for membership of the Nuclear Suppliers Group (NSG) was an “extraordinary exercise in realpolitik”, that the Indian government under Prime Minister Narendra Modi “is not easily rattled by disapproving noises at home or abroad”. One analyst referring to China’s opposition put it rather colourfully that Beijing behaved “not as an enlightened power but [...]

Pharma sector makes its mark on the world

2020-03-26T07:13:57+00:00February 9th, 2017|2017/2018, February 2017, Sector Focus/Pharma, Year|

Some of India’s leading pharmaceutical majors made their mark with acquisitions in recent months.

Aurobindo Pharma buys Portugal firm

Aurobindo PharmaceuticalsAurobindo Pharma has announced the acquisition of Portugal’s Generis Farmaceutica SA.

The Hyderabad-based company said a definitive agreement was signed by its step-down subsidiary, Agile Pharma, Netherlands. The acquisition will be from Magnum Capital Partners for an all-cash deal, the company said.

It will include a manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets or capsules annually. After the acquisition, the Aurobindo Group will be the largest in the generic pharmaceutical market in Portugal, with a portfolio of 271 generic products.

Generis has a wide portfolio of products, with a major share in therapeutic areas such as cardiovascular, central nervous system, anti-infective, and the genitourinary system.

Aurobindo expects to complete the deal by next month, after the Portuguese Competition authorities clear the deal.

For India to Go Global is natural

2018-05-18T13:04:06+00:00February 9th, 2017|2017/2018, February 2017, Go Global, Year|

One of India’s leading international businessmen traces the factors behind India’s natural instinct towards going global.  The question isn’t whether India can turn global; it is how quickly will India be accepted among the leading nations in the world. Global trade and business is not new for India. The past is replete with examples of India’s contribution to world trade; in fact, India actually taught the world how to trade, be it spices or fibres or cotton yarn. In the [...]

India has a huge role in my success

2020-03-12T08:20:18+00:00February 9th, 2017|2017/2018, February 2017, Global Indian, Year|

Pankaj Lal was among a handful of scientists to be honoured by outgoing US President Barack Obama with the Presidential Award. ‘India Global Business’ caught up with him to trace what led to this prestigious achievement and what being a Global Indian means to him.

What does an honour like the Presidential Award mean to you?

I am honoured and excited to receive this prestigious award. It’s always exciting for your peers to see the significant value in our work and for federal agencies to invest resources for this. This said, sharing the success with family, friends and students is the greatest reward.

Harnessing science for social good and developing sustainable energy and managing natural resources well are some of the grand challenges facing modern society, and I feel satisfied that that our work is contributing a bit towards improved understanding of this area. This award is a testament that hard work will be rewarded at the opportune moment, and will continue to keep me striving for more in the future.